157 related articles for article (PubMed ID: 37233811)
1. [Take-home naloxone: a building block of drug emergency prophylaxis in Germany].
Fleißner S; Stöver H; Schäffer D
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Sep; 66(9):1035-1041. PubMed ID: 37233811
[TBL] [Abstract][Full Text] [Related]
2. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
McDonald R; Campbell ND; Strang J
Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
[TBL] [Abstract][Full Text] [Related]
3. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs.
Sajwani HS; Williams AV
Harm Reduct J; 2022 Oct; 19(1):117. PubMed ID: 36266701
[TBL] [Abstract][Full Text] [Related]
5. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
[TBL] [Abstract][Full Text] [Related]
6. Take-Home Naloxone Kits: Attitudes and Likelihood-Of-Use Outcomes from a European Survey of Potential Overdose Witnesses.
McDonald R; Breidahl S; Abel-Ollo K; Akhtar S; Clausen T; Day E; Kelleher M; McAuley A; Petersen H; Sefranek M; Thiesen H; Strang J
Eur Addict Res; 2022; 28(3):220-225. PubMed ID: 35114666
[TBL] [Abstract][Full Text] [Related]
7. Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.
Lintzeris N; Monds LA; Bravo M; Read P; Harrod ME; Gilliver R; Wood W; Nielsen S; Dietze PM; Lenton S; Shanahan M; Jauncey M; Jefferies M; Hazelwood S; Dunlop AJ; Greenaway M; Haber P; Ezard N; Malcom A
Drug Alcohol Rev; 2020 Jan; 39(1):55-65. PubMed ID: 31774221
[TBL] [Abstract][Full Text] [Related]
8. Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?
Marino R; Landau A; Lynch M; Callaway C; Suffoletto B
Addiction; 2019 Sep; 114(9):1575-1581. PubMed ID: 31013394
[TBL] [Abstract][Full Text] [Related]
9. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
[TBL] [Abstract][Full Text] [Related]
10. Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.
Moustaqim-Barrette A; Dhillon D; Ng J; Sundvick K; Ali F; Elton-Marshall T; Leece P; Rittenbach K; Ferguson M; Buxton JA
BMC Public Health; 2021 Mar; 21(1):597. PubMed ID: 33771150
[TBL] [Abstract][Full Text] [Related]
11. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.
Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E
Public Health Rep; 2017; 132(5):563-569. PubMed ID: 28750193
[TBL] [Abstract][Full Text] [Related]
12. Is a randomised controlled trial of take home naloxone distributed in emergency settings likely to be feasible and acceptable? Findings from a UK qualitative study exploring perspectives of people who use opioids and emergency services staff.
Sampson FC; Hughes J; Long J; Buykx P; Goodacre SW; Snooks H; Edwards A; Evans B; Jones J; Moore C; Johnston S
BMC Emerg Med; 2024 Apr; 24(1):75. PubMed ID: 38679713
[TBL] [Abstract][Full Text] [Related]
13. Design details for overdose education and take-home naloxone kits: Codesign with family medicine, emergency department, addictions medicine and community.
Sellen K; Goso N; Halleran L; Mulvale-Fletcher A; Sarmiento F; Ligabue F; Handford C; Klaiman M; Milos G; Wright A; Charles M; Sniderman R; Hunt R; Parsons JA; Leece P; Hopkins S; Shahin R; Jüni P; Morrison L; Campbell DM; Strike C; Orkin A;
Health Expect; 2022 Oct; 25(5):2440-2452. PubMed ID: 35909312
[TBL] [Abstract][Full Text] [Related]
14. Knowledge of Opioid Overdose and Attitudes to Supply of Take-Home Naloxone Among People with Chronic Noncancer Pain Prescribed Opioids.
Nielsen S; Peacock A; Lintzeris N; Bruno R; Larance B; Degenhardt L
Pain Med; 2018 Mar; 19(3):533-540. PubMed ID: 28340185
[TBL] [Abstract][Full Text] [Related]
15. Lessons learned from ramping up a Canadian Take Home Naloxone programme during a public health emergency: a mixed-methods study.
Young S; Williams S; Otterstatter M; Lee J; Buxton J
BMJ Open; 2019 Oct; 9(10):e030046. PubMed ID: 31662368
[TBL] [Abstract][Full Text] [Related]
16. [First Aid Training for Drug Overdose in Opioid Addicts and Provision of Take-Home Naloxone on Release from Prison: Feasibility Study from the Bavarian Model Project].
Wodarz-von Essen HJ; Wolstein J; Pogarell O; Wodarz N
Gesundheitswesen; 2023 Jun; 85(6):568-572. PubMed ID: 36126950
[TBL] [Abstract][Full Text] [Related]
17. Rethinking 'carriage' of take-home naloxone.
McDonald R; Parkin S; Eide D; Neale J; Clausen T; Metrebian N; Carter B; Strang J
Int J Drug Policy; 2021 Sep; 95():103253. PubMed ID: 33848942
[TBL] [Abstract][Full Text] [Related]
18. A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS.
Metrebian N; Carter B; Eide D; McDonald R; Neale J; Parkin S; Dascal T; Mackie C; Day E; Guterstam J; Horsburgh K; Kåberg M; Kelleher M; Smith J; Thiesen H; Strang J
BMC Public Health; 2023 Aug; 23(1):1608. PubMed ID: 37612698
[TBL] [Abstract][Full Text] [Related]
19. Yes, not now, or never: an analysis of reasons for refusing or accepting emergency department-based take-home naloxone.
Kestler A; Giesler A; Buxton J; Meckling G; Lee M; Hunte G; Wilkins J; Marks D; Scheuermeyer F
CJEM; 2019 Mar; 21(2):226-234. PubMed ID: 29789030
[TBL] [Abstract][Full Text] [Related]
20. Community-based opioid overdose prevention programs providing naloxone - United States, 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(6):101-5. PubMed ID: 22337174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
